Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials recruiting in Minnesota

Fewer than 3 recruiting trials found.

All Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials nationally

1

Recruiting in Minnesota

1

Cities with sites

Cities in Minnesota

Minneapolis 1

Recruiting trials in Minnesota

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
NCT07140900 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Minnesota: Minneapolis

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.